September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 20, 2019 — Orchestra BioMed Inc., in partnership with Terumo Corp. announced the company has secured ...
September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
September 17, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of ...
A discussion with Khaldoon Alaswad, M.D., director, cardiac catheterization lab, Henry Ford Hospital, on treating ...
September 13, 2019 — Rex Medical L.P. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...
September 12, 2019 — HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the ...
A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...
September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major ...
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute ST-segment elevation myocardial ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 5, 2019 — Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target ...
September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...
September 3, 2019 — Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug ...
September 20, 2019